Loading clinical trials...

COMPLETEDPhase 4NCT00191399

Bipolar Depression Study: Bipolar Depression Assessment Study on Treatment Response

The primary objective of this study is to assess the efficacy of olanzapine and fluoxetine combined on all the visits as compared with the baseline visit in patients with bipolar disorder, measured by...

Lead sponsor: Eli Lilly and Company•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITINGPhase 3

A Study of Abilify® Tablet(Aripiprazole) as an Adjunctive Treatment in the Bipolar Depression

NCT03423680 · Depression, Bipolar

Enrolling By Invitation

Study of a Vestibular Biomarker of Phase in Bipolar Disorder

NCT02827045 · Bipolar Disorder, Depression, Bipolar

SUSPENDEDPhase 4

IM Ketamine vs Midazolam for Suicidal ER Patients

NCT04640636 · Depression, Unipolar, Depression, Bipolar, and more

Not Yet RecruitingNA

Ketogenic Diet for Depression

NCT06105762 · Depressive Disorder, Major Depressive Disorder, and more

UNKNOWNPhase 1/2

Recovering Damaged Cells for Sequelae Caused by COVID-19, SARS-CoV-2

NCT04846010 · Sequelae of; Infection, Post Infection Glomerulonephritis, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: January 26, 2007Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE4

Enrollment150

Start dateMay 2004

Last updatedJan 26, 2007

Condition

Depression, Bipolar

Locations shown

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Seattle, Washington

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5PM Eastern time (UTC/GMT - 5 hours, EST) or speak with your personal physician

Bayamón

Caguas

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 26, 2007Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions